Liverpool is celebrating significant progress in its mission to end new HIV transmissions by 2030, as new data from 2024 reveals a surge in testing, increased uptake of HIV prevention medication PrEP, and a dramatic reduction in late diagnoses.<\/p>\n
As part of the city\u2019s commitment to the global Fast Track Cities initiative, Liverpool has seen:<\/p>\n
This excellent data comes at the same time as a landmark development that could see even more people access HIV PrEP. The National Institute for Health and Care Excellence (NICE) has recently endorsed cabotegravir, the UK\u2019s first long-acting injectable PrEP. This breakthrough treatment will be available via NHS sexual health services, offering a vital alternative for people who cannot take daily oral tablets.<\/p>\n
Axess Sexual Health, Liverpool\u2019s NHS sexual health provider, has confirmed it will begin offering injectable PrEP immediately, making Liverpool one of the first cities in the UK to roll out this transformative technology.<\/p>\n
Liverpool\u2019s leadership in HIV prevention continues to be recognised nationally and internationally, with innovative programmes like PrEP Express, expanded testing in emergency departments, and targeted outreach to under-served communities.<\/p>\n
Councillor Harry Doyle, Cabinet Member for Culture, Health and Wellbeing, said:<\/p>\n
\u201cWe warmly welcome the introduction of injectable HIV PrEP technology.<\/p>\n
\u201cThis is a vital addition to our prevention toolkit that has the potential to transform how people protect themselves against HIV.<\/p>\n
\u201cWe\u2019ve made great progress improving testing and PrEP access in Liverpool, and this will help us reach even more people.\u201d<\/p>\n
Professor Matthew Ashton, Director of Public Health, said:<\/p>\n
\u201cThis is excellent news for Liverpool.\u00a0 \u201cFewer people are being diagnosed late, which means better health outcomes and reduced transmission.<\/p>\n
\u201cWe have made great strides in improving testing and PrEP access in the city, and the announcement of new PrEP technologies like this, which Liverpool clinics have been piloting, will help us go further and faster.\u201d<\/p>\n
\u201cThere is still a lot more work to be done though. Our Fast Track Partnership has ambitious plans and actions to help ensure we end all new HIV transmissions by 2030.\u201d<\/p>\n
Dr Martyn Wood, Clinical Director at Axess Sexual Health, added:<\/p>\n
\u201cWe\u2019re really pleased with Liverpool\u2019s latest HIV data, which reflects the growing accessibility of testing and support across the city.<\/p>\n
\u201cIt is encouraging to see increasing numbers of people engaging with PrEP too, and we\u2019re especially excited about the role that digital PrEP pathways and new injectable technologies can play.<\/p>\n
\u201cThis is a vital tool in ensuring even more residents can benefit from this preventative option.\u201d\u00a0<\/p>\n
Find out more information on accessing PrEP or HIV testing in Liverpool here.<\/a> Find out what\u2019s good up North on our new platform, The Northern Guide.\u00a0
\nFind out the latest in Liverpool here.<\/a><\/p>\n
\nFrom the best hotels, beauty spots, days out, food and more up North \u2013 visit\u00a0thenorthernguide.com<\/a>\u00a0and follow The Northern Guide on Instagram\u00a0HERE.<\/a><\/p>\n